<DOC>
	<DOCNO>NCT02394899</DOCNO>
	<brief_summary>There significant risk factor poor early cognitive development , , neurocognitive deficit demonstrate pre-school child sickle cell disease ( SCD ) . This project assess efficacy use evidence-based early stimulation program , combine component help parent cope stress , deliver six routine monthly clinic visit parent child sickle cell disease . It hop innovation improve parental psychological outcome , well child developmental outcome .</brief_summary>
	<brief_title>Improving Parental Psychosocial Functioning Early Developmental Outcomes Children With Sickle Cell Disease</brief_title>
	<detailed_description>Children sickle cell disease ( SCD ) risk various complication , many arise suddenly call problem solve skill parent . They also risk neurocognitive delay ; may become evident pre-school year . Previous research group demonstrate improved developmental outcome parental intervention incorporate play technique high risk healthy pre-school child . The aim study determine usefulness child SCD similar developmental intervention augment lesson problem solving . The study randomize control trial . Parents infant Hb SS ( homozygous sickle cell disease ) Sβ0 -thalassemia disease identify newborn screen initial year study invite participate . They randomize intervention control . Parental stress , infant 's development hemoglobin level measure recruitment six month . The intervention occur monthly Penadur ( intramuscular Benzathine Penicillin ) visit include supervise play child use inexpensive toy participation solve problem may arise parent child SCD . At end study , control dyad also give toy use intervention . All parent give result child 's developmental assessment appropriate referral make deficit identify . The study minimal risk . Every effort make maintain patient confidentiality . Respect , maximum protection best interest research subject maintain .</detailed_description>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Stress , Psychological</mesh_term>
	<criteria>Infant sickle cell disease : SS Sβ0 thalassemia Attending Sickle Cell Unit , Jamaica routine care</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>SCD</keyword>
	<keyword>early childhood intervention</keyword>
	<keyword>parental stress</keyword>
	<keyword>neurocognition</keyword>
</DOC>